Literature DB >> 7731071

Severe anemia: a risk factor for glomerular injury in sickle cell disease.

M Faulkner1, E A Turner, J Deus, K Phillips, C Weaver, O Taiwo, O Omitowoju.   

Abstract

Approximately 15% to 20% of patients with sickle cell disease have proteinuria. Proteinuria, particularly albuminuria, is the hallmark of glomerular injury. This study examines risk factors for glomerular injury as indicated by urinary albumin excretion (UAE) 30 microgram/minute, directly related to sickle cell disease. A total of seven patients were enrolled between September 1992 and March 1993. Fasting blood chemistries, complete blood cell count, 24-hour urine for protein and creatinine clearance, and glomerular filtration rate determined by 125 I-iothalamate were obtained for each patient. The results indicated that the lower the hematocrit, the higher the UAE rate. Low hematocrits have served as a protective mechanism in sickle cell disease by reducing blood viscosity and thus decreasing the number of vaso-occlusive crises. However, severe anemia appears to have an indirect adverse effect on the kidney in sickle cell disease.

Entities:  

Mesh:

Year:  1995        PMID: 7731071      PMCID: PMC2607821     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  20 in total

1.  Studies on abnormal hemoglobins. VIII. The gelling phenomenon of sickle cell hemoglobin: its biologic and diagnostic significance.

Authors:  K SINGER; L SINGER
Journal:  Blood       Date:  1953-11       Impact factor: 22.113

2.  Anaemia and nitrogen retention in patients with chronic renal failure.

Authors:  M H ROSCOE
Journal:  Lancet       Date:  1952-03-01       Impact factor: 79.321

3.  The kidney in sickle cell anemia.

Authors:  E Bourke
Journal:  J Assoc Acad Minor Phys       Date:  1992

4.  Renal pathology in adults over 40 with sickle-cell disease.

Authors:  A G Morgan; D J Shah; W Williams
Journal:  West Indian Med J       Date:  1987-12       Impact factor: 0.171

Review 5.  Sickle cell nephropathy: new insights into its pathophysiology.

Authors:  P E de Jong; L W Statius van Eps
Journal:  Kidney Int       Date:  1985-05       Impact factor: 10.612

6.  Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme.

Authors:  R J Falk; J Scheinman; G Phillips; E Orringer; A Johnson; J C Jennette
Journal:  N Engl J Med       Date:  1992-04-02       Impact factor: 91.245

Review 7.  Sickle cell anemia: beta s-gene-cluster haplotypes as prognostic indicators of vital organ failure.

Authors:  D R Powars
Journal:  Semin Hematol       Date:  1991-07       Impact factor: 3.851

8.  Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality.

Authors:  D R Powars; D D Elliott-Mills; L Chan; J Niland; A L Hiti; L M Opas; C Johnson
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

9.  Renal function in patients over 40 with homozygous sickle-cell disease.

Authors:  A G Morgan; G R Serjeant
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-11

10.  Serum erythropoietin (EST) titers in anemia.

Authors:  G de Klerk; P C Rosengarten; R J Vet; R Goudsmit
Journal:  Blood       Date:  1981-12       Impact factor: 22.113

View more
  1 in total

Review 1.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.